Critical Meeting for Domestic Supply Chain in the Pharmaceutical Industry

A significant step is being taken to increase domestic production capacity in the Turkish pharmaceutical industry. TİYSAT (Technology, Pharmaceutical and Domestic Industry Cluster) will organize a B2B Business Opportunities Event with Artkim MICE and Artkim Fuarcılık on 14 May at Rumeli Han, bringing together all stakeholders in the sector.

The event at this historic venue, which hosted pharmaceutical activities during the Ottoman period, aims to strengthen business collaborations in the sector by bringing together domestic pharmaceutical manufacturers and domestic suppliers.

All stages of pharmaceutical manufacturing on a single platform
At the event, which will take place with table participation exclusive to TİYSAT members, manufacturers of machinery, raw materials, software and consumables will have the opportunity to hold one-to-one meetings with decision-makers in the pharmaceutical sector. The organization is intended to contribute to strengthening the domestic supply chain and developing sustainable business collaborations.

The event will respond to an important need in the sector by bringing together domestic companies and manufacturers operating at different stages of the pharmaceutical production process. Participants will have the opportunity to evaluate solutions that will improve production processes on-site and establish new business connections.

"We aim to increase domestic production capacity"
TİYSAT Board Chairman Erdinç Yaşrin commented on the importance of the organization as follows:
"With this structure encompassing all stages of the sector from pharmaceutical manufacturers to raw materials and equipment suppliers, software and automation solutions to logistics and consumables, we aim to increase domestic production capacity and strengthen the global competitiveness of the Turkish pharmaceutical industry. Our event at Rumeli Han on 14 May will unite the legacy of this historic venue, which hosted pharmaceutical activities during the Ottoman period, with our vision of modern innovation and strategic collaboration. Through this special meeting, we aim to create a strategic platform that will shape the future of the Turkish pharmaceutical industry around domestic production and open the way for permanent and high-value-added business collaborations in the sector."

"A new equation in global competition"
Artkim Group Founder and CEO Ahmet Güler highlighted the sectoral importance of the event with the following remarks:
"The pharmaceutical industry stands at the forefront of sectors that play a decisive role in countries' development, not only through its economic size but also through its strategic importance. The basic condition for achieving sustainable success in a sector of this scale is having a strong, integrated and domestic supply chain structure. Our aim with this event is not only to make our domestic manufacturers visible but also to connect them directly with decision-makers and open the way for permanent and high-value-added business collaborations. Today, global competition is shaped not only by production capacity but also by supply chain management, technology development and collaboration capability. We position the TİYSAT B2B Event as a strategic platform from this perspective, bringing all stakeholders in the sector together on the same ground. We believe this organization will make significant contributions to strengthening the Turkish pharmaceutical industry around domestic production and increasing its international competitiveness."

Aim to strengthen global competition with domestic technology
The TİYSAT B2B Business Opportunities Event aims to contribute to Turkish pharmaceutical industry reaching a stronger position in global markets through its approach centered on domestic technology and production capacity. The event, which will take place within the scope of 14 May Scientific Pharmacy Day, will bring together all stakeholders in the sector around a common vision.

The organization, which aims to generate new business collaborations based on domestic production, stands out as a strong platform where strategic decisions are shaped and future production models are built.